logo
Plus   Neg
Share
Email

CorMedix Gets FDA Approval To Start Clinical Trial For Neutrolin

CorMedix Inc. (CRMD) Monday said the U.S. Food and Drug Administration has approved initiating a clinical study for Neutrolin in the United States.

"Neutrolin is being developed to help prevent catheter-related infections and thrombosis," said Antony Pfaffle, Chief Scientific Officer of CorMedix.

The company's investigational new drug application for Neutrolin includes a Phase 3 protocol in hemodialysis patients with a central venous catheter, CorMedix said.

CorMedix is also developing an Phase 3 protocol for Neutrolin to prevent catheter related infections in oncology patients receiving total parenteral nutrition.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration (FDA) has gone ahead with the approval of antiviral drug remdesivir as first treatment for COVID-19, notwithstanding last week's findings by the World Health Organization (WHO) that the drug is not effective for COVID-19 treatment. Thursday, Gilead Sciences announced that the FDA approved remdesivir, sold under the brand name Veklury. Integrated payments firm American Express Co. (AXP) reported Friday that net income for the third quarter declined to $1.1 billion or $1.30 per share from $1.8 billion or $2.08 per share in the prior-year quarter. Consolidated total revenues, net of interest expense, also decreased 20 percent to $8.8... The Federal Trade Commission or FTC has launched a new fraud reporting platform, using which, consumers can easily report fraud and all other consumer issues directly to the regulator. In a statement, the FTC said its new website, ReportFraud.ftc.gov, will provide a streamlined and user-friendly way to submit reports about scams, frauds, and bad business practices.
Follow RTT